Clinical Trial Update: Daily Low-level Red Light and 0.01% Low-dose Atropine for Myopia Prevention [NA]

View source ↗

Summary

A completed clinical trial evaluating daily low-level red light therapy combined with 0.01% atropine for the prevention of myopia, sponsored by Beijing Tongren …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine 0.01% (low-dose atropine) (atropine)
• Low-level red-light therapy

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Myopia | NA | Status: COMPLETED